Timothy E. Newhook

Mutation Status of <i>RAS, TP53</i> , and <i>SMAD4</i> is Superior to Mutation Status of <i>RAS</i> Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases

Yoshikuni Kawaguchi, Scott Kopetz, Timothy E. Newhook et al. · Clinical Cancer Research · 2019 · 174 citations

Medicine, Molecular Genetics, Oncology +17

CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer

Alex D. Michaels, Timothy E. Newhook, Sara J. Adair et al. · Clinical Cancer Research · 2017 · 104 citations · Full text

Medicine, Immunology, Oncology +17

Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration

Gaya Spolverato, Yuhree Kim, Sorin Alexandrescu et al. · Annals of Surgical Oncology · 2014 · 99 citations

Medicine, Oncology, Surgery +13

Late accidental dislodgement of a percutaneous endoscopic gastrostomy tube: an underestimated burden on patients and the health care system

Laura H. Rosenberger, Timothy E. Newhook, Bruce D. Schirmer et al. · Surgical Endoscopy · 2011 · 91 citations · Full text

Medicine, Surgery, Gastroenterology +11

Inhibition of the Growth of Patient-Derived Pancreatic Cancer Xenografts with the MEK Inhibitor Trametinib Is Augmented by Combined Treatment with the Epidermal Growth Factor Receptor/HER2 Inhibitor Lapatinib

Dustin M. Walters, James Lindberg, Sara J. Adair et al. · Neoplasia · 2013 · 87 citations · Full text

Medicine, Oncology, Pharmacology +17